Haitong Securities
-
RemeGen, a Chinese biopharmaceutical company, has rolled out a Hong Kong IPO that could be worth up to HK$3.99bn ($514.5m).
-
Ping An Insurance-backed Lufax Holdings has covered its $2.36bn US listing. Global heavyweight investors flocked to the long-awaited deal.
-
Gland Pharma, a subsidiary of Shanghai Fosun Pharmaceutical Group, has won approval for its IPO from India’s securities regulator, according to a source close to the deal.
-
Lufax Holdings, a personal finance services platform, has opened books for its offering of American depositary shares (ADS). It is aiming to raise up to $2.36bn.
-
Chinese data centre operator GDS Holdings has covered the books for its Hong Kong secondary offering, just hours after launching a deal that could be worth about $1.6bn.
-
Asia’s dollar bond market has been swamped with new deals this week. Thursday was no different, with corporate borrowers from Greater China alone raising just over $3bn between them.
-
KWG Living Group Holdings, a property manager, and real estate developer Radiance Holdings launched bookbuilding for their Hong Kong IPOs on Friday.
-
Four bond issuers from Greater China followed the Chinese ministry of finance into the dollar market on Wednesday, snapping up $1.4bn between them.
-
Three high yield Chinese property issuers turned to the offshore bond market on Monday, raising $950m between them.
-
Excellence Commercial Property and Facilities Management Group has closed its IPO early on the back of strong investor demand. It is looking to price its deal at the top of the range, according to a source close to the listing.
-
Chinese startup Dida, a ride-sharing platform, is looking to float on Hong Kong’s stock exchange, having filed a draft prospectus with the bourse.
-
Weihai City Commercial Bank has bagged HK$2.9bn ($374.2m) after pricing its IPO at the bottom of the marketed range, according to a source close to the deal.